CIPROFLOXACIN

Ciprofloxacin Adverse Events Reported to the FDA Over Time

How are Ciprofloxacin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ciprofloxacin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ciprofloxacin is flagged as the suspect drug causing the adverse event.

Most Common Ciprofloxacin Adverse Events Reported to the FDA

What are the most common Ciprofloxacin adverse events reported to the FDA?

Arthralgia	941 (1.66%)
Tendon Rupture	715 (1.26%)
Pain In Extremity	714 (1.26%)
Tendonitis	678 (1.19%)
Pyrexia	627 (1.1%)
Renal Failure Acute	591 (1.04%)
Diarrhoea	586 (1.03%)
Drug Interaction	578 (1.02%)
Nausea	559 (.98%)
Dizziness	502 (.88%)
Rash	493 (.87%)
	Show More
Pain	453 (.8%)
Vomiting	433 (.76%)
Headache	431 (.76%)
Paraesthesia	430 (.76%)
Pruritus	420 (.74%)
Myalgia	405 (.71%)
Asthenia	401 (.71%)
Insomnia	387 (.68%)
Confusional State	381 (.67%)
Tendon Disorder	350 (.62%)
Fatigue	349 (.61%)
Anxiety	344 (.61%)
Dyspnoea	341 (.6%)
Oedema Peripheral	338 (.6%)
Gait Disturbance	334 (.59%)
Hypoaesthesia	334 (.59%)
Tendon Pain	323 (.57%)
Muscular Weakness	301 (.53%)
Urinary Tract Infection	301 (.53%)
Tremor	282 (.5%)
Drug Ineffective	281 (.49%)
Rotator Cuff Syndrome	281 (.49%)
Depression	257 (.45%)
Erythema	257 (.45%)
Toxic Epidermal Necrolysis	257 (.45%)
Malaise	252 (.44%)
Renal Failure	243 (.43%)
Abdominal Pain	240 (.42%)
Back Pain	238 (.42%)
Convulsion	238 (.42%)
Muscle Spasms	225 (.4%)
Feeling Abnormal	223 (.39%)
Hypersensitivity	221 (.39%)
International Normalised Ratio Incr...	220 (.39%)
Thrombocytopenia	220 (.39%)
Burning Sensation	218 (.38%)
Drug Hypersensitivity	217 (.38%)
Dehydration	216 (.38%)
Joint Swelling	214 (.38%)
Condition Aggravated	209 (.37%)
Sepsis	209 (.37%)
Urticaria	208 (.37%)
Musculoskeletal Pain	201 (.35%)
Stevens-johnson Syndrome	196 (.35%)
Hypotension	193 (.34%)
Tinnitus	193 (.34%)
Vision Blurred	188 (.33%)
Alanine Aminotransferase Increased	187 (.33%)
Palpitations	186 (.33%)
Abdominal Pain Upper	185 (.33%)
Weight Decreased	185 (.33%)
Rhabdomyolysis	183 (.32%)
Abasia	182 (.32%)
Neuropathy Peripheral	180 (.32%)
Chills	178 (.31%)
Multi-organ Failure	178 (.31%)
Blood Creatinine Increased	177 (.31%)
Chest Pain	175 (.31%)
Rash Maculo-papular	175 (.31%)
Loss Of Consciousness	174 (.31%)
Hypoglycaemia	173 (.3%)
Tachycardia	172 (.3%)
Fall	163 (.29%)
Hallucination	160 (.28%)
Pneumonia	157 (.28%)
Aspartate Aminotransferase Increase...	156 (.27%)
Agitation	151 (.27%)
Heart Rate Increased	150 (.26%)
Electrocardiogram Qt Prolonged	146 (.26%)
Rash Erythematous	146 (.26%)
Drug Rash With Eosinophilia And Sys...	145 (.26%)
Somnolence	136 (.24%)
Dysphagia	134 (.24%)
Respiratory Failure	133 (.23%)
Anaemia	132 (.23%)
Clostridium Difficile Colitis	131 (.23%)
Jaundice	131 (.23%)
Death	128 (.23%)
Neck Pain	126 (.22%)
Arthropathy	125 (.22%)
General Physical Health Deteriorati...	124 (.22%)
Blister	121 (.21%)
Blood Alkaline Phosphatase Increase...	121 (.21%)
Hepatic Failure	116 (.2%)
Hypertension	116 (.2%)
Torsade De Pointes	116 (.2%)
Atrial Fibrillation	114 (.2%)
Decreased Appetite	114 (.2%)
Cough	113 (.2%)
Panic Attack	113 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Ciprofloxacin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ciprofloxacin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ciprofloxacin

What are the most common Ciprofloxacin adverse events reported to the FDA?

Epidermal And Dermal Conditions	3622 (6.38%)
Neurological	3152 (5.55%)
Gastrointestinal Signs	2024 (3.56%)
Joint	1924 (3.39%)
Infections - Pathogen Unspecified	1884 (3.32%)
Musculoskeletal And Connective Tiss...	1772 (3.12%)
Injuries	1509 (2.66%)
Tendon, Ligament And Cartilage	1507 (2.65%)
Muscle	1472 (2.59%)
Therapeutic And Nontherapeutic Effe...	1296 (2.28%)
Renal Disorders	1230 (2.17%)
	Show More
Respiratory	1186 (2.09%)
Hepatic And Hepatobiliary	1163 (2.05%)
Cardiac Arrhythmias	1011 (1.78%)
Hematology Investigations	913 (1.61%)
Bacterial Infectious	881 (1.55%)
Gastrointestinal Motility And Defec...	834 (1.47%)
Anxiety Disorders	780 (1.37%)
Hepatobiliary	746 (1.31%)
Cardiac And Vascular Investigations	678 (1.19%)
Body Temperature Conditions	669 (1.18%)
Sleep Disorders	607 (1.07%)
Allergic Conditions	594 (1.05%)
Movement Disorders	583 (1.03%)
Deliria	565 (.99%)
Urinary Tract Signs	512 (.9%)
White Blood Cell	480 (.85%)
Vision	474 (.83%)
Headaches	471 (.83%)
Electrolyte And Fluid Balance Condi...	467 (.82%)
Seizures	421 (.74%)
Disturbances In Thinking	360 (.63%)
Renal And Urinary Tract Investigati...	358 (.63%)
Lower Respiratory Tract Disorders	352 (.62%)
Anemias Nonhemolytic And Marrow Dep...	345 (.61%)
Lifestyle Issues	337 (.59%)
Peripheral Neuropathies	315 (.55%)
Administration Site Reactions	308 (.54%)
Physical Examination Topics	308 (.54%)
Mental Impairment	307 (.54%)
Depressed Mood Disorders	302 (.53%)
Bone And Joint Injuries	298 (.52%)
Medication Errors	294 (.52%)
Decreased And Nonspecific Blood Pre...	293 (.52%)
Fungal Infectious	288 (.51%)
Skin Appendage Conditions	287 (.51%)
Oral Soft Tissue Conditions	284 (.5%)
Angiedema And Urticaria	281 (.49%)
Platelet	267 (.47%)
Inner Ear And Viiith Cranial Nerve	266 (.47%)
Cardiac Disorder Signs	263 (.46%)
Gastrointestinal Hemorrhages	257 (.45%)
Appetite And General Nutritional	237 (.42%)
Enzyme	230 (.4%)
Glucose Metabolism Disorders	223 (.39%)
Skin Vascular Abnormalities	223 (.39%)
Eye	211 (.37%)
Gastrointestinal Inflammatory Condi...	208 (.37%)
Suicidal And Self-injurious Behavio...	189 (.33%)
Coagulopathies And Bleeding Diathes...	183 (.32%)
Central Nervous System Vascular	180 (.32%)
Nephropathies	173 (.3%)
Vascular	171 (.3%)
Chemical Injury And Poisoning	165 (.29%)
Viral Infectious	158 (.28%)
Ocular Infections, Irritations And ...	156 (.27%)
Fatal Outcomes	153 (.27%)
Hearing	151 (.27%)
Metabolic, Nutritional And Blood Ga...	151 (.27%)
Changes In Physical Activity	141 (.25%)
Heart Failures	141 (.25%)
Hematological And Lymphoid Tissue T...	141 (.25%)
Mood Disorders	140 (.25%)
Vascular Hemorrhagic	134 (.24%)
Procedural And Device Related Injur...	133 (.23%)
Bone Disorders	129 (.23%)
Personality Disorders	126 (.22%)
Protein And Chemistry Analyses	126 (.22%)
Tongue Conditions	126 (.22%)
Toxicology And Therapeutic Drug Mon...	124 (.22%)
Upper Respiratory Tract Disorders	123 (.22%)
Water, Electrolyte And Mineral	123 (.22%)
Bronchial Disorders	121 (.21%)
Psychiatric	119 (.21%)
Vascular Hypertensive	119 (.21%)
Gastrointestinal Conditions	116 (.2%)
Coronary Artery	115 (.2%)
Hemolyses And Related Conditions	107 (.19%)
Product Quality Issues	107 (.19%)
Neuromuscular	103 (.18%)
Synovial And Bursal	103 (.18%)
Embolism And Thrombosis	102 (.18%)
Salivary Gland Conditions	98 (.17%)
Vascular Inflammations	95 (.17%)
Acid-base	94 (.17%)
Ocular Neuromuscular	94 (.17%)
Exocrine Pancreas Conditions	92 (.16%)
Pleural	86 (.15%)
Schizophrenia And Other Psychotic	84 (.15%)
Arteriosclerosis, Stenosis, Vascula...	82 (.14%)
Encephalopathies	82 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ciprofloxacin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ciprofloxacin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.